Harpoon Therapeutics, Inc.

  • Market Cap: Micro Cap
  • Industry: Biotechnology
  • ISIN: US41358P2056
USD
23.01
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'23
Jun'23
Mar'23
Dec'22
Sep'22
Jun'22
Mar'22
Net Sales
4.45
20.22
8.58
4.09
13.62
8.30
5.91
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
4.45
20.22
8.58
4.09
13.62
8.30
5.91
Raw Material Cost
0.24
0.57
1.10
0.91
0.71
0.72
0.76
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.05
1.56
0.14
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
4.26
3.60
3.74
3.62
4.35
4.89
5.24
Other Expenses
1.00
1.03
1.44
1.83
2.05
2.01
2.02
Total Expenditure (Excl Depreciation)
16.59
16.00
19.35
22.80
25.51
25.71
26.22
Operating Profit (PBDIT) excl Other Income
-12.1
4.2
-10.8
-18.700000000000003
-11.899999999999999
-17.4
-20.299999999999997
Other Income
23.58
0.43
-0.43
0.29
0.25
0.06
-0.01
Operating Profit (PBDIT)
11.68
5.22
-10.10
-17.51
-10.93
-16.63
-19.56
Interest
2.05
1.56
0.14
0.00
0.00
0.00
0.00
Exceptional Items
-11.20
-2.03
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
4.21
19.65
7.48
3.18
12.91
7.59
5.14
Depreciation
0.24
0.57
1.10
0.91
0.71
0.72
0.76
Profit Before Tax
-1.80
1.06
-11.34
-18.42
-11.64
-17.35
-20.32
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-1.80
1.06
-11.34
-18.42
-11.64
-17.35
-20.32
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-1.80
1.06
-11.34
-18.42
-11.64
-17.35
-20.32
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-1.80
1.06
-11.34
-18.42
-11.64
-17.35
-20.32
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
4.54
3.00
0.71
5.40
16.91
26.64
41.38
Earnings per share (EPS)
-0.46
0.28
-3.07
-5.47
-3.52
-5.25
-6.18
Diluted Earnings per share
-0.46
0.28
-3.07
-5.47
-3.52
-5.25
-6.18
Operating Profit Margin (Excl OI)
-272.91%
20.88%
-125.42%
-457.62%
-87.31%
-209.7%
-343.94%
Gross Profit Margin
-35.21%
8.06%
-119.22%
-428.22%
-80.3%
-200.34%
-331.14%
PAT Margin
-40.51%
5.25%
-132.1%
-450.48%
-85.48%
-208.97%
-344.07%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2023 is -78.22% vs 134.88% in Jun 2023

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2023 is -263.64% vs 109.73% in Jun 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2023 is -347.92% vs 149.48% in Jun 2023

stock-summary

Interest

QoQ Growth in quarter ended Sep 2023 is 25.00% vs 1,500.00% in Jun 2023

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2023 has fallen from Jun 2023

Compare Quarterly Results Of Harpoon Therapeutics, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
4.45
0.30
4.15
1,383.33%
Other Operating Income
0.00
0.00
0.00
Total Operating income
4.45
0.30
4.15
1,383.33%
Raw Material Cost
0.24
0.59
-0.35
-59.32%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
2.05
0.00
2.05
Selling and Distribution Expenses
4.26
6.65
-2.39
-35.94%
Other Expenses
1.00
1.49
-0.49
-32.89%
Total Expenditure (Excl Depreciation)
16.59
22.11
-5.52
-24.97%
Operating Profit (PBDIT) excl Other Income
-12.14
-21.81
9.67
44.34%
Other Income
23.58
1.74
21.84
1,255.17%
Operating Profit (PBDIT)
11.68
-19.48
31.16
159.96%
Interest
2.05
0.00
2.05
Exceptional Items
-11.20
35.95
-47.15
-131.15%
Gross Profit (PBDT)
4.21
-0.29
4.50
1,551.72%
Depreciation
0.24
0.59
-0.35
-59.32%
Profit Before Tax
-1.80
15.89
-17.69
-111.33%
Tax
0.00
0.00
0.00
Provisions and contingencies
0.00
0
0.00
Profit After Tax
-1.80
15.89
-17.69
-111.33%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-1.80
15.89
-17.69
-111.33%
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-1.80
15.89
-17.69
-111.33%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
4.54
-2.53
7.07
279.45%
Earnings per share (EPS)
-0.46
0.60
-1.06
-176.67%
Diluted Earnings per share
-0.46
0.60
-1.06
-176.67%
Operating Profit Margin (Excl OI)
-272.91%
-7,319.13%
0.00
7,046.22%
Gross Profit Margin
-35.21%
5,528.52%
0.00
-5,563.73%
PAT Margin
-40.51%
5,330.87%
0.00
-5,371.38%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 0.44 Million
in Sep 2023

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2023 is -78.22% vs 134.88% in Jun 2023

stock-summary

YoY Growth in quarter ended Sep 2023 is -67.65% vs 202.22% in Sep 2022

Quarterly - Consolidate Net Profit
Consolidate Net Profit -0.18 Million
in Sep 2023

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2023 is -263.64% vs 109.73% in Jun 2023

stock-summary

YoY Growth in quarter ended Sep 2023 is 84.48% vs 30.54% in Sep 2022

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -1.19 Million
in Sep 2023

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2023 is -347.92% vs 149.48% in Jun 2023

stock-summary

YoY Growth in quarter ended Sep 2023 is -6.25% vs 30.00% in Sep 2022

Quarterly - Interest
Interest 0.20 Million
in Sep 2023

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2023 is 25.00% vs 1,500.00% in Jun 2023

stock-summary

YoY Growth in quarter ended Sep 2023 is 0.00% vs 0.00% in Sep 2022

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -272.91%
in Sep 2023

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2023 has fallen from Jun 2023

stock-summary

YoY Growth in quarter ended Sep 2023 has fallen from Sep 2022